ALX Oncology
ALXO
ALXO
93 hedge funds and large institutions have $2.47B invested in ALX Oncology in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 47 increasing their positions, 17 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.73% more ownership
Funds ownership: 81.78% → 83.51% (+1.7%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
11% less capital invested
Capital invested by funds: $2.78B → $2.47B (-$311M)
Holders
93
Holding in Top 10
6
Calls
$3.96M
Puts
$900K
Top Buyers
| 1 | +$50M | |
| 2 | +$40.2M | |
| 3 | +$34.9M | |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$22.8M |
| 5 |
AG
Artal Group
Luxembourg
|
+$16.6M |
Top Sellers
| 1 | -$68.4M | |
| 2 | -$46.6M | |
| 3 | -$18.2M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$16.5M |
| 5 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
-$13.8M |